期刊档案

Pneumonologia i Alergologia Polska

ISSN 0867-7077 · eISSN 2299-8292 · Via Medica sp. z.o.o. VM Group Via Medica · Poland

Pneumonologia i Alergologia Polska 影响因子 4.5(官网公布),JCR Q1(官网公布),钻石开放获取(无 APC),免版面费,投稿社区反馈审稿约 20 周。

影响因子4.5期刊官网公布的 2025 年度值
中科院分区—未被分区表收录
审稿周期约 20 周投稿社区平均反馈
版面费免版面费钻石开放获取(无 APC)
录用比例—暂无反馈
年发文量—暂无统计

研究范围

研究范围与定位

Pneumonologia i Alergologia Polska 由 Via Medica sp. z.o.o. VM Group Via Medica 出版。按 OpenAlex 近年发文统计,该刊主要发表 Asthma and respiratory diseases、Nutrition and Health Studies、Chronic Obstructive Pulmonary Disease (COPD) Research 等主题的论文,这 3 个主题约占 25.2%,主导子领域为 Pulmonary and Respiratory Medicine。(根据 OpenAlex 主题统计与中科院分区数据生成)

AimsAdvances in Respiratory Medicine, which started publishing in 1909, is a peer-reviewed, open access, bi-monthly journal of the Polish Respiratory Society. It publishes research articles, review articles, systematic reviews, guidelines, editorials, short communications, etc. Advances in Respiratory Medicine publishes both clinical and basic research, and it is also open to the publication of phased trial work.We aim to collect high-quality and cutting-edge articles of interest in respiratory medicine and provide an efficient, reliable, and guaranteed platform for scholars and readers. Full experimental and/or methodological details must be provided for research articles. Therefore, there is no restriction on the maximum length of papers or the number of electronic multimedia and supplementary files.ScopeAdvances in Respiratory Medicine is a journal of respiratory medicine, covering allergology, immunology, oncology, and infectious diseases of the respiratory system. It welcomes manuscripts related to respiratory system structure, physiology, pathology, diagnostics, and treatment. It includes, but is not limited to, manuscripts on the following subjects: Respiratory structure and physiopathology (including basic science, molecular aspects of pathology, mechanisms of lung injury and repair, immunology of the respiratory system, etc.); Clinical problems, rehabilitation, chronic care, and respiratory medicine (in general practice and primary care); Chronic airway diseases (asthma, COPD, bronchiectasis, chronic cough, etc.); Infectious diseases of the respiratory system (including tuberculosis and non-tuberculosis mycobacterial diseases, COVID-19, AIDS, and diseases caused by bacteria, viruses, and parasites); Interstitial lung diseases (all aspects); Genetic diseases with respiratory manifestations (cystic fibrosis, A1AT deficiency, etc.); Pulmonary vascular diseases (vasculitis, pulmonary embolism, pulmonary hypertension, etc.); Rare (orphan) diseases with respiratory system involvement; Respiratory intensive care (acute critical care, noninvasive ventilatory support, oxygen therapy, etc.); Thoracic oncology (lung cancer, pleural and mediastinal malignancies, etc.); Thoracic surgery and lung transplantation; Sleep-disordered breathing; Epidemiology and environment (occupational respiratory diseases, environmental exposure, tobacco, smoking control, etc.); Respiratory diagnostics (imaging, ultrasound, lung function testing, exercise testing, microbiology, e

摘自期刊官网 Aims & Scope

主要研究主题 OpenAlex 近年发文统计,占比为近似值

  1. Asthma and respiratory diseasesMedicine8.5%
  2. Nutrition and Health StudiesMedicine8.5%
  3. Chronic Obstructive Pulmonary Disease (COPD) ResearchMedicine8.1%
  4. Lung Cancer Diagnosis and TreatmentMedicine6.6%
  5. Medical Imaging and Pathology StudiesMedicine6.6%
  6. Lung Cancer Treatments and MutationsMedicine5.4%
  7. Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedicine5.4%
  8. Building energy efficiency and sustainabilityEngineering4.3%

分区与收录

学科分区与数据库收录

中科院期刊分区表

期刊分区表( 2025年3月升级版)未收录

该期刊未被此版本分区表收录。

《新锐期刊分区表》( 2026年3月发布)未收录

该期刊未被此版本分区表收录。

期刊分区表( 2023年12月旧的升级版)未收录

该期刊未被此版本分区表收录。

期刊官网公布的 JCR / CiteScore 分区

出版商自述数据,JCR 以 Clarivate、CiteScore 以 Scopus 公布为准;与中科院分区是不同体系。出版商官网

数据库收录

DOAJLetPub

国际期刊预警名单:各版本均未列入LetPub

期刊官网自述收录

ESCIWeb of ScienceScopusMEDLINEPMCPubMedEmbase出版商官网

期刊官网列出的收录清单,未与各数据库逐一核对;Web of Science 各子库以上方记录为准。

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。

指标

影响力指标与发文规模

影响力指标

影响因子(出版商公布) 2025
4.5出版商官网 ·
五年影响因子(出版商公布) 2025
2.1出版商官网 ·
CiteScore(出版商公布)
4.5出版商官网 ·
h-index
7OpenAlex ·
i10-index
2OpenAlex ·
两年平均被引
0OpenAlex ·
Gold OA 文章占比
0%LetPub ·

不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。

审稿与录用

审稿周期与录用情况

平均审稿速度(社区反馈)
20 WeeksLetPub ·
投稿到首次决定
25.7 天出版商官网 ·
接收到发表
3.9 天出版商官网 ·
投稿到发表(期刊自报)
约 20 周DOAJ ·
评审方式
双盲同行评审DOAJ

社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。

费用与开放获取

版面费与开放获取政策

钻石开放获取(无 APC)DOAJ

所有文章开放获取,且不向作者收取文章处理费。

来源文章处理费费用减免许可证观测时间
DOAJ无文章处理费无CC BY-NC-ND
LetPub无文章处理费无—
出版商官网有,金额未公布——

费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。

投稿要求

文章类型与投稿政策(官网)

征稿中的专刊2 个,按截稿日期
  1. Pulmonary Rehabilitation: Interventions, Protocols, and Outcomes截稿
  2. Infectious Diseases in Respiratory Medicine截稿
出版商官网
投稿准备要点8 项,摘自作者指南
参考文献格式
著者-出版年制
稿件模板
提供 LaTeX 与 Word 模板
首次投稿格式
允许不按期刊格式排版(free format)
推荐审稿人
必须提供 3 位
Highlights(研究亮点)
必须提供
图文摘要
可选
投稿信(Cover letter)
必须提供
不接收
Case Reports
出版商官网 · 模型提取,逐项与原文核对
接收的文章类型18 种
  1. book reviewAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…未说明篇幅
  2. brief communicationAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…未说明篇幅
  3. brief reportAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…未说明篇幅
  4. case reportAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…未说明篇幅
  5. commentaryAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…未说明篇幅
  6. conference reportAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…未说明篇幅
  7. editorialAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…未说明篇幅
  8. hypothesisAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…未说明篇幅
  9. letterAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…未说明篇幅
  10. opinionAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…未说明篇幅
  11. perspectiveAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…未说明篇幅
  12. protocolAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…未说明篇幅
  13. registered reportAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…未说明篇幅
  14. reviewAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…未说明篇幅
  15. systematic reviewAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…未说明篇幅
  16. technical noteAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…未说明篇幅
  17. tutorialAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…未说明篇幅
  18. viewpointAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…未说明篇幅
出版商官网
官网政策摘录作者资格、利益冲突、数据可用性、出版伦理、许可与版权、开放获取、同行评审、预印本
作者资格 Authorship

MDPI follows the International Committee of Medical Journal Editors (ICMJE) guidelines which state that, in order to qualify for authorship of a manuscript, the following criteria should be observed: Make substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data for the work; Draft the work or review it critically for important intel…

原文 ↗出版商官网 ·
利益冲突 Conflicts of Interest

According to The International Committee of Medical Journal Editors, “Authors should avoid entering into agreements with study sponsors, both for-profit and non-profit, that interfere with authors’ access to all of the study’s data or that interfere with their ability to analyze and interpret the data and to prepare and publish manuscripts independently when and where they choose.” All authors mus…

原文 ↗出版商官网 ·
数据可用性 Data availability statements

Data availability statements are required for all articles published with MDPI. During the peer review and editorial decision process, authors can be asked to share existing datasets or raw data that have been analyzed in the manuscript, and whether they will be made available to other researchers following publication. Authors will also be asked for the details of any existing datasets that have …

原文 ↗出版商官网 ·
出版伦理 Publication Ethics Statement

MDPI is a member of the Committee on Publication Ethics (COPE). We fully adhere to its Code of Conduct and to its Best Practice Guidelines. The editors of this journal enforce a rigorous peer review process together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification,…

原文 ↗出版商官网 ·
许可与版权 Copyright / Open Access

Articles published in ARM will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). The copyright is retained by the author(s). MDPI will insert the following note at the end of the published text: © 2026 by the authors. Published by MDPI on behalf of the Polish Respiratory Society. Licensee MDPI, Basel, Switzerland. This article i…

原文 ↗出版商官网 ·
开放获取 Open access publication fees

If you transfer your manuscript to another open access (OA) journal, you will be charged an Article Processing Charge (APC) if your article is accepted for publication. The APC for each journal can be found on the individual journal’s website. For more information about APCs, please see here.

原文 ↗出版商官网 ·
同行评审 Editorial Process and Peer Review

All submissions are thoroughly peer-reviewed by experts within the field and undergo a structured editorial workflow designed to ensure quality, transparency, and scientific integrity. The full editorial procedure is available on the Editorial Process page and is also provided below. Pre-check Pre-check consists of a technical pre-check performed by the Editorial Office and an editorial pre-check …

原文 ↗出版商官网 ·
预印本 Preprints and Conference Papers

ARM accepts submissions that have previously been made available as preprints provided that they have not undergone peer review. A preprint is a draft version of a paper made available online before submission to a journal. MDPI operates Preprints, a preprint server to which submitted papers can be uploaded directly after completing journal submission. Note that Preprints operates independently of…

原文 ↗出版商官网 ·

摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。

基本信息

出版信息与官方入口

出版商
Via Medica sp. z.o.o. VM Group Via Medica
出版国家或地区
Poland
出版语言
English
ISSN
0867-7077
电子版 ISSN
2299-8292
官网最新一期
Volume 94(2026 年)
官方链接

常见问题

关于 Pneumonologia i Alergologia Polska 的常见问题

Pneumonologia i Alergologia Polska 的影响因子是多少?

期刊官网公布的影响因子为 4.5(2025 年度),属期刊自述数据,LetPub 暂无该刊的影响因子记录,h-index 为 7。

Pneumonologia i Alergologia Polska 的审稿周期多长?

投稿社区反馈的平均审稿速度为约 20 周。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。

Pneumonologia i Alergologia Polska 是 JCR 几区?

期刊官网公布的 JCR 分区为 Q1,分学科为 Respiratory System Q1。JCR 分区以 Clarivate 公布为准,与中科院分区是不同体系。

Pneumonologia i Alergologia Polska 的投稿格式要求是什么?

据期刊作者指南:参考文献格式:著者-出版年制;稿件模板:提供 LaTeX 与 Word 模板;首次投稿格式:允许不按期刊格式排版(free format);推荐审稿人:必须提供 3 位;Highlights:必须提供;图文摘要:可选;投稿信:必须提供。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。

Pneumonologia i Alergologia Polska 被哪些数据库收录?

据 LetPub 与 DOAJ 记录,Pneumonologia i Alergologia Polska 被 DOAJ 收录。期刊官网自述还被 ESCI、Web of Science、Scopus、MEDLINE、PMC、PubMed、Embase 收录,该清单未与各数据库逐一核对。

Pneumonologia i Alergologia Polska 是开放获取期刊吗?版面费多少?

Pneumonologia i Alergologia Polska 为钻石开放获取(无 APC)。不收取文章处理费。

来源与更新

本页事实来自 LetPub、出版商官网、OpenAlex、DOAJ;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-26 归档)。最近更新:。